Abstract
To report epidemiologic and anatomoclinical transitions of inflammatory breast cancer (IBC) in Tunisia. Data including clinico-pathological data for208 cases of T4d or PEV 3 non-metastatic breast cancer diagnosed between 2005 and 2010 were collected from patient records. Chi2 and Z tests were used to compare variables with two Tunisian historical series and a series about Arab-American patients. Thirty three percent of our patients had their first child before 23 years of age and 56% had their menarche before 12 years, 75% never receiving oral contraception. Obesity was observed in 42% of women and IBC occurred during pregnancy in 13% of cases. Tumor grade was II-III in 90% of cases, HR was negative in 52%, HER2 was over expressed in 31% and invasion of more than 3 axillary nodes occurred in 18% of patients. We observed a pCR rate of 19% after neoadjuvant treatment (anthracyline-taxane used in 79%, trastuzumab in 27% ). Compared to historical Tunisian series (since 1996), IBC epidemiology remained stable in terms of median age, menopausal status and obesity. However we observed a significant decrease in median clinical tumor size and number of positive axillary lymph nodes. Comparison to IBC in Arab-Americans showed a significa...Continue Reading
References
Dec 15, 1980·Cancer·N MouraliP H Levine
Jul 7, 2005·Journal of the National Cancer Institute·Kenneth W HancePaul H Levine
Dec 31, 2005·Clinical Breast Cancer·Monique G LêNejib Mourali
Nov 17, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S I LabidiF Ben Ayed
Mar 1, 2008·Seminars in Oncology·Paul H Levine, Carmela Veneroso
Sep 16, 2008·Cancer Detection and Prevention·Carmela VenerosoPaul H Levine
Jun 22, 2010·Cancer·Hamouda BoussenPaul H Levine
Oct 27, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer A SchlichtingSofia D Merajver
Mar 27, 2012·International Journal of Radiation Oncology, Biology, Physics·Sana RehmanRahul D Tendulkar
Jun 27, 2012·Breast Cancer Research and Treatment·Jennifer A SchlichtingSofia D Merajver
Feb 20, 2013·SpringerPlus·Ali MasihaMohammad Reza Karimi
Sep 3, 2013·The Lancet Oncology·Lotfi ChouchaneKonduru S R Sastry
Sep 21, 2013·Journal of the National Cancer Institute·Laleh Amiri-KordestaniJo Anne Zujewski
Sep 21, 2013·Journal of the National Cancer Institute·Catherine SchairerDiana L Miglioretti
Oct 3, 2013·Clinical Breast Cancer·Akina NatoriHideko Yamauchi
Dec 25, 2013·Annals of Surgical Oncology·Bryan GoldnerSteven L Chen
Mar 29, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DawoodA M Gonzalez-Angulo
Apr 29, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marilys CorbexPaolo Boffetta
Citations
Dec 7, 2016·PLoS Medicine·Gerald GohCharles Swanton
Jul 7, 2018·BMC Cancer·Meriem SlaouiMariam Amrani
Jan 27, 2019·Molecular and Clinical Oncology·Maroua ManaiHamouda Boussen
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Oumaima ZidiSoumaya Kouidhi